Cyclic adenosine monophosphate-responsive element-binding protein activation predicts an unfavorable prognosis in patients with hepatocellular carcinoma.
Onco Targets Ther
; 7: 873-9, 2014.
Article
in En
| MEDLINE
| ID: mdl-24926200
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Onco Targets Ther
Year:
2014
Document type:
Article
Country of publication:
New Zealand